文献
J-GLOBAL ID:202002259786003353
整理番号:20A2757271
SLC6A1の過剰発現は前立腺癌における薬物耐性および予後不良と関連する【JST・京大機械翻訳】
Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer
著者 (20件):
Chen Chaojiang
(Guangdong Provincial Institute of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China)
,
Chen Chaojiang
(Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, China)
,
Chen Chaojiang
(Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China)
,
Cai Zhiduan
(Guangdong Provincial Institute of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China)
,
Cai Zhiduan
(Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, China)
,
Zhuo Yangjia
(Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, China)
,
Xi Ming
(Department of Urology, Huadu District People’s Hospital, Southern Medical University, Guangzhou, China)
,
Lin Zhuoyuan
(Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China)
,
Jiang Funeng
(Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, China)
,
Liu Zezhen
(Guangdong Provincial Institute of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China)
,
Liu Zezhen
(Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, China)
,
Wan Yueping
(Department of Urology, Huadu District People’s Hospital, Southern Medical University, Guangzhou, China)
,
Zheng Yu
(Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China)
,
Li Jianxin
(Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China)
,
Zhou Xing
(Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China)
,
Zhu Jianguo
(Department of Urology, Guizhou Provincial People’s Hospital, The Affiliated Hospital of Guizhou Medical University, Guiyang, China)
,
Zhong Weide
(Guangdong Provincial Institute of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China)
,
Zhong Weide
(Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, China)
,
Zhong Weide
(Department of Urology, Huadu District People’s Hospital, Southern Medical University, Guangzhou, China)
,
Zhong Weide
(Urology Key Laboratory of Guangdong Province, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China)
資料名:
BMC Cancer (Web)
(BMC Cancer (Web))
巻:
20
号:
1
ページ:
1-10
発行年:
2020年
JST資料番号:
U7305A
ISSN:
1471-2407
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)